CMS approves Medicaid waivers to treat substance use disorders
The Centers for Medicare & Medicaid Services last week approved Section 1115 waivers allowing Minnesota and Nebraska to implement demonstration projects to increase access and treatment for Medicaid beneficiaries with opioid and other substance use disorders. Both states will receive Medicaid matching funds for treatment in facilities that meet the definition of an institution for mental diseases, which include hospitals and other residential treatment facilities with more than 16 beds that are primarily engaged in diagnosis, treatment or care of persons with mental diseases. CMS outlined additional waiver opportunities last November for states to treat SUDs and mental illness.
Related News Articles
Headline
A Centers for Disease Control and Prevention report highlights differences in substance use among U.S. high school students. The report, which combined data…
Headline
The Department of Health and Human Services Office for Civil Rights released new guidance on statutory and regulatory requirements under 42 CFR Part 2, which…
Headline
The Health Resources and Services Administration announced Sept. 25 that it awarded $89.3 million in grants to expand access to substance use disorder…
Headline
The Centers for Medicare & Medicaid Services Sept. 25 announced the launch of a new initiative measuring quality in Medicaid and the Children’s Health…
Headline
The Substance Abuse and Mental Health Services Administration Sept. 25 announced that it awarded $247.9 million in grants for services expanding access to…
Headline
The Substance Abuse and Mental Health Services Administration announced Sept. 18 that it awarded $42.3 million in grants to states and territories to support…